Antitumor efficacy of photodynamic therapy using novel nanoformulations of hypocrellin photosensitizer SL052

Photochemistry and Photobiology

Volumn 88, Issue 1, 2012, Pages 188-193

  Korbelik, Mladen ^a   Madiyalakan, Ragupathy ^b   Woo, Thomas ^b   Haddadi, Azita ^c  

^a BRITISH COLUMBIA CANCER AGENCY   (Canada)

^b Quest PharmaTech Inc   (Canada)

^c UNIVERSITY OF SASKATCHEWAN   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG DERIVATIVE; PERYLENE; PHOTOSENSITIZING AGENT; QUINOXALINE DERIVATIVE; SL 052;

ARTICLE; NANOTECHNOLOGY; PHOTOCHEMOTHERAPY;

NANOTECHNOLOGY; PERYLENE; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; QUINOXALINES;

MUS;

EID: 84855357284     PISSN: 00318655     EISSN: 17511097     Source Type: Journal    
DOI: 10.1111/j.1751-1097.2011.01035.x     Document Type: Article

References (33)

1. Agostinis, P., K. Berg, K. A. Cengel, T. H. Foster, A. W. Girotti, S. O. Gollnick, S. Hahn, M. R. Hamblin, A. Juzeniene, D. Kessel, M. Korbelik, J. Moan, P. Mroz, D. Nowis, J. Piette, B. C. Wilson, and, J. Golab, (2011) Photodynamic therapy of cancer: An update. CA Cancer J. Clin. 61 (4), 250-281.
2. Konan, Y. N., R. Gurny, and, E. Allemann, (2002) State of the art in the delivery of photosensitizers for photodynamic therapy. J. Photochem. Photobiol. B 66, 89-106. (Pubitemid 34240266)
3. Chaterjee, D. K., L. S. Fong, and, Y. Zhang, (2008) Nanoparticles in photodynamic therapy: An emerging paradigm. Adv. Drug Deliv. Rev. 60, 1627-1637.
4. Kumari, A., S. K. Yadav, and, S. C. Yadav, (2010) Biodegradable polymeric nanoparticles based drug delivery systems. Colloids Surf. B Biointerfaces 75, 1-18.
5. Jain, R., N. H. Shah, A. W. Malick, and, C. T. Rhodes, (1998) Controlled drug delivery by biodegradable poly(ester) devices: Different preparative approaches. Drug Dev. Ind. Pharm. 24, 703-727. (Pubitemid 28346446)
6. Jain, R. A., (2000) The manufacturing techniques of various drug loaded biodegradable poly (lactide-coglycolide) (PLGA) devices. Biomaterials 21, 2475-2490.
7. Alshamsan, A., A. Haddadi, S. Hamdy, J. Samuel, A. El-Kadi, H. Uludag, and, A. Lavasanifar, (2010) STAT3 silencing in dendritic cells by siRNA polyplexes encapsulated in PLGA nanoparticles for the modulation of anticancer immune response. Mol. Pharm. 7, 1643-1654.
8. Hamdy, S., A. Haddadi, A. Shayeganpour, J. Samuel, and, A. Lavasanifar, (2011) Activation of antigen specific T cell responses by mannan-decorated PLGA nanoparticles. Pharm. Res. 28 (9), 2288-2301.
9. Haddadi, A., P. Elamanchili, A. Lavasanifar, S. Das, J. Shapiro, and, J. Samuel, (2008) Delivery of rapamycin by PLGA nanoparticles enhances its suppressive activity on dendritic cells. J. Biomed. Mater. Res. 84A, 885-898. (Pubitemid 351294999)
10. Hamdy, S., A. Haddadi, V. Somayaji, D. Ruan, and, J. Samuel, (2007) The pharmaceutical analysis of synthetic lipid A-based vaccine adjutants in poly (d,l-lactic-co-glycolic acid) nanoparticle formulations. J. Pharm. Biomed. Anal. 44, 914-923. (Pubitemid 47095185)
11. Mundargi, R. C., V. R. Babu, V. Rangaswamy, P. Patel, and, T. M. Aminabhavi, (2008) Nano/micro technologies for delivering macromolecular therapeutics using poly(d,l,-lactide-co-glycolide) and its derivatives. J. Control. Release 125, 193-209.
12. Fadel, M., K. Kassab, and, D. A. Fadeel, (2010) Zinc phthalocyanine- loaded PLGA biodegradable nanoparticles for photodynamic therapy in tumor-bearing mice. Lasers Med. Sci. 25, 283-292.
13. Ricci-Júnior, E., and, J. M. Marchetti, (2006) Preparation, characterization, photocytotoxicity assay of PLGA nanoparticles containing zinc (II) phthalocyanine for photodynamic therapy use. J. Microencapsul. 23, 523-538. (Pubitemid 44446594)
14. Ricci-Júnior, E., and, J. M. Marchetti, (2006) Zinc (II) phthalocyanine loaded PLGA nanoparticles for photodynamic therapy use. Int. J. Pharm. 310, 187-195. (Pubitemid 43287983)
15. Pagonis, T. C., J. Chen, C. R. Fontana, H. Devalapally, K. Ruggiero, X. Song, F. Foschi, J. Dunham, Z. Skobe, H. Yamazaki, R. Kent, A. C. Tanner, M. M. Amiji, and, N. S. Soukos, (2010) Nanoparticle-based endodontic antimicrobial photodynamic therapy. J. Endod. 36, 322-328.
16. Hu, Z., Y. Pan, J. Wang, J. Chen, J. Li, and, L. Ren, (2009) Meso-tetra (carboxyphenyl) porphyrin (TCPP) nanoparticles were internalized by SW480 cells by a clathrin-mediated endocytosis pathway to induce high photocytotoxicity. Biomed. Pharmacother. 63, 155-164.
17. Gomes, A. J., C. N. Lunardi, and, A. C. Tedesco, (2007) Characterization of biodegradable poly(d,l-lactide-co-glycolide) nanoparticles loaded with bacteriochlorophyll-a for photodynamic therapy. Photomed. Laser Surg. 25, 428-435. (Pubitemid 350059049)
18. Saxena, V., M. Sadoqi, and, J. Shao, (2006) Polymeric nanoparticulate delivery system for indocyanine green: Biodistribution in healthy mice. Int. J. Pharm. 308, 200-204. (Pubitemid 43097253)
19. Vargas, A., B. Pegaz, E. Debefve, Y. Konan-Knuakou, N. Lange, J. P. Ballini, H. van den Bergh, R. Gurny, and, F. Delie, (2004) Improved photodynamic activity of porphyrin loaded into nanoparticles: An in vivo evaluation using chick embryos. Int. J. Pharm. 286, 131-145. (Pubitemid 39410481)
20. Konan, Y. N., M. Berton, R. Gurny, and, E. Allémann, (2003) Enhanced photodynamic activity of meso-tetra(4-hydroxyphenyl)porphyrin by incorporation into sub-200 nm nanoparticles. Eur. J. Pharm. Sci. 18, 241-249. (Pubitemid 36349275)
21. Konan, Y. N., R. Cherny, J. Favet, M. Berton, R. Gurny, and, E. Allémann, (2003) Preparation and characterization of sterile sub-200 nm meso-tetra(4-hydroxylphenyl)porphyrin-loaded nanoparticles for photodynamic therapy. Eur. J. Pharm. Biopharm. 55, 115-124. (Pubitemid 36120503)
22. Korbelik, M., S. Merchant, and, N. Huang, (2009) Exploitation of immune response-eliciting properties of hypocrellin photosensitizer SL052-based photodynamic therapy for eradication of malignant tumors. Photochem. Photobiol. 85, 1418-1424.
23. Xiao, Z., R. J. Owen, L. Weiyang, J. Tulip, K. Brown, T. Woo, and, R. B. Moore, (2010) Lipophilic photosensitizer administration via the prostate arteries for photodynamic therapy of the canine prostate. Photodiagnosis Photodyn. Ther. 7, 106-114.
24. Meng, Y., C. Zou, R. Madiyalakan, T. Woo, M. Huang, X. Yang, E. Swanson, J. Chen, and, J. Z. Xing, (2010) Water-soluble and biocompatible sono/photosensitizer nanoparticles for enhanced cancer therapy. Nanomedicine 5, 1559-1569.
25. Khurana, D., E. A. Martin, J. L. Kasperbauer, B. W. O'Malley Jr,., D. R. Salomao, L. Chen, and, S. E. Strome, (2001) Characterization of spontaneously arising murine squamous cell carcinoma (SCC VII) as a prerequisite for head and neck cancer immunotherapy. Head Neck 23, 899-906. (Pubitemid 32862295)
26. Ferrari, M., (2005) Cancer nanotechnology: Opportunities and challenges. Nat. Rev. Cancer 5, 161-171. (Pubitemid 40314948)
27. Alexis, F., E. Pridgen, L. K. Molnar, and, O. C. Farokhzad, (2008) Factors affecting the clearance and biodistribution of polymeric nanoparticles. Mol. Pharm. 5, 1-18.
28. Wohlfart, S., A. S. Khalansky, S. Gelperina, O. Maksimenko, C. Bernreuther, M. Glatzel, and, J. Kreuter, (2011) Efficient chemotherapy of rat glioblastoma using doxorubicin-loaded PLGA nanoparticles with different stabilizers. PLoS ONE 6 (1), e19121.
29. Heath, F., P. Haria, and, C. Alexander, (2007) Varying polymer architecture to deliver drugs. AAPS J. 9 (2), E235-E240.
30. Sunshine, J. S., M. I. Akanda, D. Li, K. L. Kozielski, and, J. J. Green, (2011) Effects of base polymer hydrophobicity and end-group modification on polymeric gene delivery. Biomacromolecules 12 (10), 3592-3600.
31. Aliabadi, H. M., B. Landry, R. K. Bahadur, A. Neamnark, O. Suwantong, and, H. UludaÄ, (2011) Impact of lipid substitution on assembly and delivery of siRNA by cationic polymers. Macromol. Biosci. 11 (5), 662-672.
32. Acharya, S., and, S. K. Sahoo, (2011) PLGA nanoparticles containing various anticancer agents and tumor delivery by EPR effect. Adv. Drug Deliv. Rev. 63, 170-183.
33. Greish, K., (2010) Enhanced permeability and retention (EPR) effect for anticancer nanomedicine drug targeting. Methods Mol. Biol. 624, 25-37.